Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naina McCann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|June 6, 2018
An aggressive form of <i>Haemophilus parainfluenzae</i> infective endocarditis presenting with limb weaknessNaina McCann, Mohamad Fahed Barakat, Frank Schafer
Lancet (London, England)|June 29, 2024
Towards paratyphoid control: the vital role of the challenge modelNaina McCann, Margarete Paganotti Vicentine, Andrew J Pollard
Current Opinion in Immunology|June 1, 2022
Viral vector vaccinesNaina McCann, Daniel O'Connor, Teresa Lambe, et al.
Plos One|July 29, 2022
Antimicrobial agents for the treatment of enteric fever chronic carriage: A systematic reviewNaina McCann, Peter Scott, Christopher M Parry, et al.
Frontiers in Immunology|September 11, 2024
The use of controlled human infection models to identify correlates of protection for invasive <i>Salmonella</i> vaccinesNaina McCann, Margarete Paganotti Vicentine, Young Chan Kim, et al.
The Lancet. Infectious Diseases|April 30, 2019
Ceftriaxone-resistant Salmonella Typhi in a traveller returning from a mass gathering in IraqGauri Godbole, Naina McCann, Stephen Morris Jones, et al.
Open Forum Infectious Diseases|June 5, 2023
What Should We Be Recommending for the Treatment of Enteric Fever?Christopher M Parry, Farah N Qamar, Samita Rijal, et al.
BMJ Open|May 24, 2023
Accelerating clinical development of a live attenuated vaccine against <i>Salmonella</i> Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of <i>Salmonella</i> Paratyphi A infection in healthy adult volunteersNaina McCann, Katherine Emary, Nisha Singh, et al.
BMJ Open|January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocolMargarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The New England Journal of Medicine|October 29, 2025
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A VaccineNaina McCann, Margarete Paganotti Vicentine, Narges Ebrahimi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|June 6, 2018
An aggressive form of <i>Haemophilus parainfluenzae</i> infective endocarditis presenting with limb weaknessNaina McCann, Mohamad Fahed Barakat, Frank Schafer
Lancet (London, England)|June 29, 2024
Towards paratyphoid control: the vital role of the challenge modelNaina McCann, Margarete Paganotti Vicentine, Andrew J Pollard
Current Opinion in Immunology|June 1, 2022
Viral vector vaccinesNaina McCann, Daniel O'Connor, Teresa Lambe, et al.
Plos One|July 29, 2022
Antimicrobial agents for the treatment of enteric fever chronic carriage: A systematic reviewNaina McCann, Peter Scott, Christopher M Parry, et al.
Frontiers in Immunology|September 11, 2024
The use of controlled human infection models to identify correlates of protection for invasive <i>Salmonella</i> vaccinesNaina McCann, Margarete Paganotti Vicentine, Young Chan Kim, et al.
The Lancet. Infectious Diseases|April 30, 2019
Ceftriaxone-resistant Salmonella Typhi in a traveller returning from a mass gathering in IraqGauri Godbole, Naina McCann, Stephen Morris Jones, et al.
Open Forum Infectious Diseases|June 5, 2023
What Should We Be Recommending for the Treatment of Enteric Fever?Christopher M Parry, Farah N Qamar, Samita Rijal, et al.
BMJ Open|May 24, 2023
Accelerating clinical development of a live attenuated vaccine against <i>Salmonella</i> Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of <i>Salmonella</i> Paratyphi A infection in healthy adult volunteersNaina McCann, Katherine Emary, Nisha Singh, et al.
BMJ Open|January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocolMargarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
The New England Journal of Medicine|October 29, 2025
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A VaccineNaina McCann, Margarete Paganotti Vicentine, Narges Ebrahimi, et al.
Pageof 1